[SY168] Samstag, 26. April 2003 (Saal 4) 11:30-13:00

Symposium

How diuretics affect symptoms and prognosis in heart failure — diuretic and non-diuretic actions

(organised by Hoffmann La Roche AG)

I1266 Introduction.
M. Wehling (Mannheim)

I1267 Diuretics in heart failure — pathophysiological bases and therapeutic consequenses.
R. Düsing (Bonn)

I1268 Impact of diuretic therapy on clinical outcomes and prognosis in heart failure — what makes the difference?
C. Brater (Indianapolis IN, US)

I1269 Diuretics in heart failure — pharmacoeconomic consequences of different outcomes.
J.G.F. Cleland (Cottingham, GB)

I1270 Torasemide and myocardial remodelling in patients with heart failure.
J. Diez (Pamplona, ES)